LobbyingTichenor Ventures lobbying by quarter
Tichenor Ventures's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q1 2019; the issues it reports most are Aviation/Aircraft/Airlines and Medical/Disease Research/Clinical Labs.
Tichenor Ventures
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2019
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2019 | $0 | 1 |
| Q2 2019 | $0 | 1 |
| Q3 2019 | $0 | 1 |
| Q4 2019 | $0 | 1 |
| Q1 2020 | $0 | 1 |
| Q2 2020 | $0 | 1 |
| Q3 2020 | $0 | 1 |
| Q4 2020 | $0 | 1 |
| Q1 2021 | $0 | 1 |
| Q2 2021 | $0 | 1 |
| Q3 2021 | $0 | 1 |
| Q4 2021 | $0 | 1 |
| Q1 2022 | $0 | 1 |
| Q2 2022 | $0 | 1 |
| Q3 2022 | $0 | 1 |
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Aviation and airlines$0 · 30 reports
- Medical research and clinical labs$0 · 30 reports
- Pharmacy$0 · 30 reports
- Budget and appropriations$0 · 22 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES30 reports
- SENATE30 reports
Firms it paid
| Firm | ||
|---|---|---|
| Iseman & Associates | $0 | 30 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Iseman & Associates | Under $5,000 |
| 04/20for Q1 | Iseman & Associates | Under $5,000 |
| 01/16for Q4 2025 | Iseman & Associates | Under $5,000 |
| 25/10/17for Q3 2025 | Iseman & Associates | Under $5,000 |
| 25/09/03for Q1 2020 | Iseman & Associates | Under $5,000 |
| 25/07/20for Q2 2025 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q1 2025 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q4 2024 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q3 2024 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q2 2024 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q1 2024 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q4 2023 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q3 2023 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q2 2023 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q1 2023 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q4 2022 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q3 2022 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q2 2022 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q4 2019 | Iseman & Associates | Under $5,000 |
| 25/05/09for Q3 2019 | Iseman & Associates | Under $5,000 |